Literature DB >> 12419296

von Willebrand factor and coronary heart disease: prospective study and meta-analysis.

P H Whincup1, J Danesh, M Walker, L Lennon, A Thomson, P Appleby, A Rumley, G D O Lowe.   

Abstract

AIMS: To determine whether circulating von Willebrand factor concentrations are prospectively related to risk of coronary heart disease in the general population. METHODS AND
RESULTS: We measured baseline von Willebrand factor values in the stored serum samples of 625 men with major coronary events and in 1266 controls 'nested' in a prospective study of 5661 men aged 40-59 years, recruited from general practices in 18 British towns in 1978-1980 and followed up for 16 years for fatal coronary heart disease and non-fatal myocardial infarction. We conducted a meta-analysis of previous relevant studies to place our results in context. Men in the top third of baseline von Willebrand factor values (tertile cutoff >126 IU.dl(-1)) had an odds ratio for coronary heart disease of 1.83 (95% confidence interval 1.43-2.35; 2P <0.0001) compared with those in the bottom third (tertile cutoff <90 IU.dl(-1)), after adjustments for age and town. The odds ratio was little changed after further adjustment for risk factors (1.82, 95% CI 1.37-2.41), and was not significantly different in an analysis restricted to the 404 cases and 1007 controls without baseline evidence of coronary heart disease (odds ratio 1.53, 95% CI 1.10-2.12). A meta-analysis of all relevant population-based prospective studies (including the present study) yielded a combined odds ratio of 1.5 (95% CI 1.1-2.0). von Willebrand factor values were strongly correlated with Helicobacter pylori seropositivity and circulating concentrations of C-reactive protein (2 P<0.0001 for each), but not with smoking, blood lipids, or most other measured risk factors.
CONCLUSION: Though circulating von Willebrand factor concentrations may be associated with incident coronary heart disease, further studies are needed to determine the extent to which this is causal. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419296     DOI: 10.1053/euhj.2001.3237

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  66 in total

Review 1.  Measurement of thrombosis and its prevention.

Authors:  Gordon D O Lowe
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

3.  Relation between birth weight and soluble markers of endothelial function in middle aged subjects.

Authors:  E A McIntyre; L Parker; M S Pearce; J Gerrard; N Sattar; A W Craft; M Walker
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

Review 4.  Exercise and psychobiological processes: implications for the primary prevention of coronary heart disease.

Authors:  Mark Hamer
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Factor IX and deep vein thrombosis.

Authors:  Gordon Lowe
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

6.  Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.

Authors:  T Wethal; J Kjekshus; J Røislien; T Ueland; A K Andreassen; R Wergeland; P Aukrust; S D Fosså
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

7.  Genetic predictors of depressive symptoms in cardiac patients.

Authors:  Jeanne M McCaffery; Qing Ling Duan; Nancy Frasure-Smith; Amina Barhdadi; Francois Lespérance; Pierre Théroux; Guy A Rouleau; Marie-Pierre Dubé
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

Review 8.  Beyond immunohaematology: the role of the ABO blood group in human diseases.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

9.  Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.

Authors:  Jie Dong; Yan-Jun Li; Zhi-Kai Yang; Rong Xu
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls.

Authors:  Roland von Känel; Sonia Ancoli-Israel; Joel E Dimsdale; Paul J Mills; Brent T Mausbach; Michael G Ziegler; Thomas L Patterson; Igor Grant
Journal:  Gerontology       Date:  2009-12-03       Impact factor: 5.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.